EDMONTON, Alberta, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or
the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce that it has now filed an additional 9
provisional patent applications with the United States Patent and Trademark Office (the “USPTO”), bringing the total number of
patent applications filed by the Company in 2018 to 40. The inventions covered in these patent applications relate to methods and
systems for improving the safety, potency, flavour, and experience of cannabinoid extracts used in the manufacturing of food &
beverage products.
Further Details: Patents for Innovating Cannabinoid-Infused Food & Beverage Manufacturing
Processes
These provisional patent applications provide methods that are expected to be critical in the
cannabinoid-infused food and beverage industry. The methods relate to the measuring, dosing, and testing of cannabinoid additives
used in food & beverage manufacturing processes. Because cannabinoids such as cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”)
are extracted from plant biomass, the ability to produce food and beverage products with consistent and measurable cannabinoid
content and potency is highly desired by both customers and regulators.
Several of these inventions provide novel solutions poised for widespread adoption in the flavouring of
cannabinoid-infused food & beverage products. Traditionally, edible and drinkable cannabis products have been interlinked with
flavours and aromas associated with the marijuana plant. There is a need in the market to meet customer demand for
cannabinoid-infused food & beverage products with a variety of desirable flavours.
Further, some of these provisional patent applications cover functional packaging elements for
cannabinoid-infused food & beverage products that Radient’s extensive analysis indicates will be in line with the direction of the
cannabis industry. These packaging elements are intended to provide additional safety measures and an improved user experience.
These provisional applications were first filed in the USPTO to create a priority date and allow for future
filings in other selected jurisdictions, as appropriate, including Canada and Europe.
Dr. Steven Splinter, Founder and CTO of Radient, stated: “With nearly 20 years of experience in developing and
manufacturing extracts for our customers, providing our solutions to the food & beverage sector of the cannabis industry is a
natural extension of our core capabilities.”
About Radient
Radient extracts natural compounds from a range of biological materials using microwave assisted processing (“MAP™”), a patented
technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 23,000
square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical,
food, beverage, natural health, and personal care markets. Since 2016, Radient has expanded its offerings to enter the cannabinoids
market utilizing its MAP™ platform to process and extract cannabinoids including cannabidiol and tetrahydrocannabinol from cannabis
biomass. Visit www.radientinc.com? for more information.
SOURCE: Radient Technologies Inc.
Denis Taschuk, Chief Executive Officer, dtaschuk@radientinc.com,
(780) 465-1318;
Mike Cabigon, Chief Operating Officer, mcabigon@radientinc.com,
(780) 465-1318
Caitlin Cheadle, Director of Communications, ccheadle@radientinc.com
Forward Looking Information:
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation.
Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations; the
Company’s ability to receive approval for patent applications; the Company’s ability to expand into the U.S.; the Company’s ability
to expand its operations in Europe and Canada; the Company’s ability to grow its business in the cannabis sector and food and
beverage industries; and the Company’s future plans. Generally, forward-looking information can be identified by the use of
forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”,
“forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state
that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”.
Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual
results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those
expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could
cause actual results to differ materially from those contained in forward-looking information, there may be other factors that
cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be
accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking
information, except in accordance with applicable securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
